These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9049041)

  • 1. C5a receptors are detectable on mast cells in normal human skin and in psoriatic plaques but not in weal and flare reactions or in uticaria pigmentosa by immunohistochemistry.
    Werfel T; Oppermann M; Begemann G; Götze O; Zwirner J
    Arch Dermatol Res; 1997 Jan; 289(2):83-6. PubMed ID: 9049041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human mast cell line HMC-1 expresses C5a receptors and responds to C5a but not to C5a(desArg).
    Werfel T; Oppermann M; Butterfield JH; Begemann G; Elsner J; Götze O; Zwirner J
    Scand J Immunol; 1996 Jul; 44(1):30-6. PubMed ID: 8693289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the tissue distribution of the rat C5a receptor and inhibition of C5a-mediated effects through the use of two MoAbs.
    Rothermel E; Götze O; Zahn S; Schlaf G
    Scand J Immunol; 2000 Oct; 52(4):401-10. PubMed ID: 11013012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic characterization of skin lesions in urticaria pigmentosa and mastocytomas.
    Haas N; Hamann K; Grabbe J; Algermissen B; Czarnetzki BM
    Arch Dermatol Res; 1995; 287(3-4):242-8. PubMed ID: 7541189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The C5a receptor is expressed in normal renal proximal tubular but not in normal pulmonary or hepatic epithelial cells.
    Fayyazi A; Scheel O; Werfel T; Schweyer S; Oppermann M; Götze O; Radzun HJ; Zwirner J
    Immunology; 2000 Jan; 99(1):38-45. PubMed ID: 10651939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells.
    Füreder W; Agis H; Willheim M; Bankl HC; Maier U; Kishi K; Müller MR; Czerwenka K; Radaszkiewicz T; Butterfield JH; Klappacher GW; Sperr WR; Oppermann M; Lechner K; Valent P
    J Immunol; 1995 Sep; 155(6):3152-60. PubMed ID: 7673728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of C5a receptors on human eosinophils and inhibition of eosinophil effector functions by anti-C5a receptor (CD88) antibodies.
    Elsner J; Oppermann M; Kapp A
    Eur J Immunol; 1996 Jul; 26(7):1560-4. PubMed ID: 8766561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of MHC class II antigen on mast cells at sites of inflammation in human skin.
    Lipski S; Grabbe J; Henz BM
    Exp Dermatol; 1996 Apr; 5(2):120-4. PubMed ID: 8734922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct tissue site-specific requirements of mast cells and complement components C3/C5a receptor in IgG immune complex-induced injury of skin and lung.
    Baumann U; Chouchakova N; Gewecke B; Köhl J; Carroll MC; Schmidt RE; Gessner JE
    J Immunol; 2001 Jul; 167(2):1022-7. PubMed ID: 11441111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway.
    Nilsson G; Johnell M; Hammer CH; Tiffany HL; Nilsson K; Metcalfe DD; Siegbahn A; Murphy PM
    J Immunol; 1996 Aug; 157(4):1693-8. PubMed ID: 8759757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probing the human receptor for C5a anaphylatoxin with site-directed antibodies. Identification of a potential ligand binding site on the NH2-terminal domain.
    Oppermann M; Raedt U; Hebell T; Schmidt B; Zimmermann B; Götze O
    J Immunol; 1993 Oct; 151(7):3785-94. PubMed ID: 8376805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two novel mast cell phenotypic markers, monoclonal antibodies Ki-MC1 and Ki-M1P, identify distinct mast cell subtypes.
    Hamann K; Haas N; Grabbe J; Welker P; Czarnetzki BM
    Br J Dermatol; 1995 Oct; 133(4):547-52. PubMed ID: 7577581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced expression of chemotactic receptors in multiple sclerosis lesions.
    Müller-Ladner U; Jones JL; Wetsel RA; Gay S; Raine CS; Barnum SR
    J Neurol Sci; 1996 Dec; 144(1-2):135-41. PubMed ID: 8994115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of the C5a receptor on the main cell types of rat liver as demonstrated with a novel monoclonal antibody and by C5a anaphylatoxin-induced Ca2+ release.
    Schlaf G; Schieferdecker HL; Rothermel E; Jungermann K; Götze O
    Lab Invest; 1999 Oct; 79(10):1287-97. PubMed ID: 10532591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perivascular mast cells in urticaria pigmentosa.
    Sweet WL; Smoller BR
    J Cutan Pathol; 1996 Jun; 23(3):247-53. PubMed ID: 8793660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glomerular cells do not express the C5a receptor in human glomerulonephritis.
    Lhotta K; König P; Mayer G; Oppermann M
    Nephrol Dial Transplant; 2000 Nov; 15(11):1888-9. PubMed ID: 11071988
    [No Abstract]   [Full Text] [Related]  

  • 17. CD88 antibodies specifically bind to C5aR on dermal CD117+ and CD14+ cells and react with a desmosomal antigen in human skin.
    Werfel T; Zwirner J; Oppermann M; Sieber A; Begemann G; Drommer W; Kapp A; Götze O
    J Immunol; 1996 Aug; 157(4):1729-35. PubMed ID: 8759762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptors for the anaphylatoxin C5a (CD88) on human mesangial cells.
    Wilmer WA; Kaumaya PT; Ember JA; Cosio FG
    J Immunol; 1998 Jun; 160(11):5646-52. PubMed ID: 9605171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
    Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP
    Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense homology boxes in C5a receptor and C5a anaphylatoxin: a new method for identification of potentially active peptides.
    Baranyi L; Campbell W; Okada H
    J Immunol; 1996 Nov; 157(10):4591-601. PubMed ID: 8906838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.